There is 1 paper on isolated paracentral acute middle maculopathy in aging research: 1 observational study in people.
1 paper studies it2 findings
See all 1 papers on isolated paracentral acute middle maculopathy
“Relative to those with PAMM + RVD, risk of CVE was significantly higher in patients with iPAMM, adjusted for age and sex (hazard ratio: 6.37, 95% confidence interval 1.68-24.14, P = .017).”
- Humans1
Effects
1Visual acuity
upin humans1
1 study
Visual acuity
upin humans1
Isolated paracentral acute middle maculopathy is linked with better visual acuity in humans (older iPAMM patients) (0.7 to 0.2 logMAR).
“At baseline, older iPAMM patients mean best corrected visual acuity of 0.7 (0-1.8) logarithm of the minimum angle resolution, which improved significantly to 0.2 (0-1.30) logarithm of the minimum angle resolution at the latest visit (P = .033).”
Humansolder iPAMM patients
American journal of ophthalmology
Associations
1Cardiovascular events
upin humans1HR 6.37
1 study
Cardiovascular events
upin humans1HR 6.37
Isolated paracentral acute middle maculopathy is linked with a higher risk of cardiovascular events in humans (relative to PAMM + RVD) (HR 6.37, 95% CI 1.68-24.14).
“Relative to those with PAMM + RVD, risk of CVE was significantly higher in patients with iPAMM, adjusted for age and sex (hazard ratio: 6.37, 95% confidence interval 1.68-24.14, P = .017).”
Humansrelative to PAMM + RVD
American journal of ophthalmology
Latest
American Journal of Ophthalmology
Paracentral Acute Middle Maculopathy and Risk of Cardiovascular Disease, Stroke, and Death: A Longitudinal Study
Cohort study of 43 peopleCardiovascular disease